Nancy Reau News Today

Pamela Kushner, MD, FAAFP; Nancy Reau, MD; Arun B. Jesudian, MD, and Kimberly Brown, MD, discuss the impact of hepatic encephalopathy (HE) on patients and their families, as well as strategies for improving patient outcomes.

In this segment of our 6-part discussion on updates and unmet needs within the management of hepatitis B virus focuses on the most pressing unmet needs in HBV for 2024.

In this segment of our 6-part discussion on updates and unmet needs within the management of hepatitis B virus focuses on advances in the pathophysiology of hepatitis b virus for 2024.

In this segment of our 6-part discussion on updates and unmet needs within the management of hepatitis B virus focuses on how advancing understanding of HBV DNA integration is influencing care in 2024.

In this segment of our 6-part discussion on updates and unmet needs within the management of hepatitis B virus focuses on the need to improve HBV screening and vaccination.

Phase 2b data from the AHFIRM trial is anticipated soon. Reau discusses what the agent may show in treating alcohol-associated hepatitis.

A large cohort study using biopsy-proven cases confirms a link outside of known metabolic risk factors.

WEDNESDAY, June 14, 2023 (HealthDay News) -- Hepatitis C is a viral infection of the liver no one wants to catch, so knowing how that can happen can be critical.

WEDNESDAY, June 14, 2023 (HealthDay News) -- Hepatitis C is a viral infection of the liver no one wants to catch, so knowing how that can happen can be critical.

Hepatitis C is often missed in the early stages of infection, so you need to know what symptoms might spell trouble.